Patent · US Active

Compounds and methods for inhibiting EMT pathways to treat cancer, organ fibrosis and metabolic disorders

US11078159B2 · kind B2 · utility

1Cited by
1References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 19, 2018
Grant dateAug 3, 2021
Priority date—
Expiry dateFeb 19, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.